Bayer and Dr. Reddy's sign marketing and distribution agreement for second brand of Vericiguat in India
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Total transaction value of the divestment is Rs. 3,660 million
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Subscribe To Our Newsletter & Stay Updated